Related Experiment Video

Updated: Jul 16, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K

Symptom control

Gilberto Barranco-Lampón1,2, Raúl Martínez-Castro3, Luara Arana-Luna4

  • 1Servicio de Hematología, Hospital General de México, Ciudad de México, México.

Gaceta Medica De Mexico
|September 21, 2023
PubMed

Insights

Patients with myeloproliferative neoplasms (MPN) often suffer from debilitating symptoms due to increased inflammatory cytokines. Controlling these symptoms is a key treatment goal alongside preventing complications.

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Background:

  • Myeloproliferative neoplasms (MPN) are associated with various complications, including splenomegaly, microvascular issues, and thrombohemorrhagic events.
  • Patients with MPN frequently report a substantial symptom burden.
  • Elevated levels of circulating inflammatory cytokines contribute significantly to the symptom burden in MPN.

Purpose of the Study:

  • To highlight the significant impact of inflammatory cytokines on symptom burden in MPN patients.
  • To emphasize the importance of symptom control as a primary treatment objective in MPN management.

Main Methods:

  • Review of existing literature on MPN pathophysiology and symptomatology.
  • Analysis of the role of inflammatory cytokines in MPN-related symptoms.
  • Evaluation of current treatment strategies for MPN.

Main Results:

  • Inflammatory cytokines are a major driver of symptoms in MPN.
  • Symptom burden in MPN significantly impacts patients' quality of life.
  • Effective MPN treatment requires addressing both complications and symptoms.

Conclusions:

  • Symptom control is a critical component of comprehensive MPN management.
  • Targeting inflammatory cytokines may offer a therapeutic strategy for improving quality of life in MPN patients.
Keywords:
Myeloproliferative neoplasmsNeoplasias mieloproliferativasPruritoPruritusSymptomsSíntomas

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.4K
Control of Eating Behavior Using a Novel Feedback System04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.0K

Related Concept Videos

Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
7.8K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
200
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
60
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
236